Yan Gong
· Associate ProfessorUniversity of Florida · Pharmacotherapy and Translational Research
Active 2000–2025
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
Yan Gong, Ph.D., is an Associate Professor in the Department of Pharmacotherapy and Translational Research at the University of Florida (UF) College of Pharmacy and the UF Center for Pharmacogenomics and Precision Medicine. She received her Ph.D. in Pharmaceutics in 2004 from the UF College of Pharmacy and a Master’s Degree in Statistics in 2003 from the UF Department of Statistics. Prior to joining the UF faculty in 2005, she completed a one-year post-doctoral Fellowship in Cardiovascular Pharmacogenomics at the UF Center for Pharmacogenomics. Dr. Gong's research focuses on the pharmacogenomics of efficacy and adverse responses of antihypertensive medications, as well as serious adverse drug events such as medication-related osteonecrosis of the jaw (MRONJ) and cardiotoxicities related to cancer therapies (Cardio-Oncology). She has authored over 170 peer-reviewed publications. In addition to her research activities, Dr. Gong is involved in teaching multiple graduate and professional courses at UF College of Pharmacy and College of Medicine. She is currently the course co-coordinator for Pharmacogenomic and Genomic Data Analysis (PHA6449), a required graduate course for her department.
Research topics
- Medicine
- Internal medicine
- Cardiology
- Biology
- Genetics
- Immunology
- Cancer research
- Bioinformatics
- Biochemistry
Selected publications
European Heart Journal · 2021 · 91 citations
AIMS: Inflammation plays an important role in cardiovascular disease (CVD) development. The NOD-like receptor protein-3 (NLRP3) inflammasome contributes to the development of atherosclerosis in animal models. Components of the NLRP3 inflammasome pathway such as interleukin-1β can therapeutically be targeted. Associations of genetically determined inflammasome-mediated systemic inflammation with CVD and mortality in humans are unknown. METHODS AND RESULTS: We explored the association of genetic N…
The Pharmacogenomics Journal · 2020 · 44 citations
JAMA Network Open · 2021 · 42 citations
Importance: Accumulating evidence indicates that higher blood pressure (BP) variability from one physician office visit to the next (hereafter referred to as visit-to-visit BP variability) is associated with poor outcomes. Short-term measurement (throughout 1 year) of visit-to-visit BP variability in high-risk older patients may help identify patients at increased risk of death. Objective: To evaluate whether short-term visit-to-visit BP variability is associated with increased long-term mortali…
SIRT1 Gene SNP rs932658 Is Associated With Medication-Related Osteonecrosis of the Jaw
Journal of Bone and Mineral Research · 2020 · 24 citations
Senior authorCorresponding> 0.8) with rs7896005. To validate the association between these SNPs and MRONJ, we genotyped these three SNPs on the germline DNA from 104 cancer patients of European ancestry treated with iv BPs (46 cases and 58 controls). Multivariable logistic regression analysis showed the minor alleles of these three SNPs were associated with lower odds for MRONJ. The odds ratios (95% confidence interval) and p values were 0.351 (0.164-0.751; p = 0.007) for rs3758391, 0.351 (0.164-0.751; p = 0.007) for rs9…
Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score
Journal of the American College of Cardiology · 2024 · 23 citations
Frequent coauthors
- 745 shared
Julie A. Johnson
University of North Carolina at Chapel Hill
- 708 shared
Rhonda M. Cooper‐DeHoff
University of Florida
- 530 shared
Amber L. Beitelshees
University of Maryland, Baltimore
- 504 shared
John G. Gums
University of Florida
- 496 shared
Eric Boerwinkle
The University of Texas Health Science Center at Houston
- 475 shared
Stephen T. Turner
Australian Regenerative Medicine Institute
- 316 shared
Caitrin W. McDonough
University of Florida
- 310 shared
Carl J. Pepine
University of Florida
Education
- 2004
Ph.D., Pharmaceutics
University of Florida
- 2003
M.S., Statistics
University of Florida
Similar researchers at University of Florida
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Yan Gong
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup
